Pesquisa

Edição
Título
Autores
Health schools for patients: physicians’ perspective
Mamedova E., Batjushin M., Bykovskaja T.
The clinical value of the determination of matrix metalloproteinases and their inhibitors in children with autosomal dominant polycystic kidney disease
Bashirova Z., Vozdvizhenskaya E., Osmanov I.
Early diagnosis and correction of nutritive status abnormalities in predialysis and hemodialysis chronic kidney disease patients
Aleksandorva I., Milovanov Y., Dobrosmyslov I.
Chronic kidney disease: risk factors for development and progression
Krupnova M., Bondarenko M., Marasaev V.
Kidney in patients survived in hantaan and puumala virus-induced nephropathy
Sirotin B.
Matrix metalloproteinases in priogression of hereditary kidney disease
Bashirova Z.
Renal function parameters and endothelial disfunction in patients with arterial hypertension
Rebrov A., Kuklina A.
OTsENKA VLIYaNIYa POChEChNYKh FAKTOROV RISKA I PARAMETROV KORONARNOY ATEROSKLEROTIChESKOY BLYaShKI NA VEROYaTNOST' RAZVITIYa RETsIDIVA STENOKARDII U BOL'NYKh, PODVERGShIKhSYa REVASKULYaRIZATsII MIOKARDA
Levitskaya E., Batyushin M., Terent'ev V., Dyuzhikov A., Khripun A.
RASPROSTRANENNOST' KhRONIChESKOY BOLEZNI POChEK U BOL'NYKh PSORIATIChESKIM ARTRITOM
Rebrov A., Kargal'skaya O.
CLINICAL SIGHNIFICANCE OF ADIPONECTINEMIA IN DEVELOPMENT OF TARGET ORGAN-DAMAGE IN METABOLIC SYNDROME, ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Saginova E., Severova M., Gallyamov M., Ermakov N., Rodina A., Fomin V., Mukhin N.
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
Fomin V., Pulin A., Rameev V., Sedov V., Meshkov A., Roshchupkina S., Panasyuk V., Kozlovskaya L., Mukhin N.
Disturbances of calcium-phosphate metabolism disturbances in chronic kidney disease stage III - V
Milovanova L., Milovanov Y., Kozlovskaya L.
Anaemia correction in diabetic nephropathy: target haemoglobin values and cardiovascular complications
Shestakova M., Martynov S.
Prevalence of diabetic nephropathy and chronic kidney disease in diabetes mellitus in Russian Federation
Maslova O., Suntsov Y., Shestakova M., Kazakov I., Vikulova L., Sukhareva O., Martynov S., Maslova O., Suntsov Y., Shestakova M., Kazakova I., Vikulova L., Sukhareva O., Martynov S.
FROM SARALASIN TO SARTANS: HISTORY OF THE ANGIOTENSIN II RECEPTOR BLOCKADE
Fomin V., Kurashov M., Fomin V., Kurashov M.
Difficulties in renal anemia treatment. Role of prolonged erythropoietin receptor activators
Kozlovskaya L., Milovanov Y., Milovanova L., Dobrosmyslov I., Kozlovskaya L., Milovanov Y., Milovanova L., Dobrosmislov I.
ACE inhibitors and nephroprotection in chronic proteinuric nephropathies
Moiseev S., Arutyunov G., Fomin V., Moiseev S., Arutyunov G., Fomin V.
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance
Ryasnyansky V., Shostka G., Anikonova L.
Early predictors of kidney damage in children and adolescents with type 1 diabetes mellitus
Zeinebekova A., Umarova A., Usmanova D., Turkara A., Kovalchuk V., Dyussenova S.
Insulin resistance in chronic kidney disease pages of history
Bachmakov I., Fedoseev A., Denisova V.
Chronic Kidney Disease: Non-invasive Diagnosis of Chronic Renal Failure by Monochrome Nanoparticle Analysis
Choi E.
Kidney damage in Covid-19: clinical-pathogenetic aspects and management of patients with chronic kidney disease
Abdullaev S., Igamberdiyeva R., Sharapov O.
Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection
Rey S., Vasina N., Berdnikov G., Marchenkova L., Kotenko O.
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
Ilyushkina A., Baydakova G., Bychkov I., Buruleva N., Zakharova E.
Hyperkalemia - clinical significance, treatment approaches
Shutov E.
The relationship of bendopnea and change in renal filtration function in patients with chronic heart failure
Dragunov D., Sokolova A., Gasanova A., Arutyunov G.
Acute kidney injury in patients who underwent cardiac surgery
Iskanderov B.
The use of ketoacids in chronic kidney disease
Batushin M.
Effect of chronic obstructive pulmonary disease on the development and progression of chronic kidney disease
Bolotova E., Dudnikova A., Yavlyanskaya V.
Left ventricular diastolic dysfunction of the left ventricle in glomerulopathies
Aiypova D., Beishebaeva N., Kaliev R.
Obesity and kidney disease: hidden consequences of the epidemic
Kovesdy C., Furth S., Zoccali C.
Sudden cardiac death in chronic kidney disease
Moukhin N., Fomin V., Moisseev S., Kiyakbaev G.
Fibroblast growth factor type 23 and chronic kidney disease
Nimgirova A., Esayan A., Kayukov I.
Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases
Eraliev A., Demeubaeva D., Naushabaeva A., Kabulbaev K., Chingaeva G., Abeouva B., Dosym S., Kanatbaeva A.
MDRD study: role in clinical nephrology
Moukhin N., Kozlovskaya L., Fomin V., Milovanov Y.
Predictive medicine and clinical nephrology
Moukhin N.
Zheleza sakharat: rol' v lechenii anemii pri khronicheskoy bolezni pochek
Fomin V.
Otsenka funktsii pochek s ispol'zovaniem pokazatelya skorosti klubochkovoy fil'tratsii v ambulatornopoliklinicheskoy praktike
Kurochkina O.
CARDIO-RENAL ANEMIA SYNDROME: CORRECTION WITH IRON SUCROSE
Fomin V., Kozlovskaya L., Milovanov Y., Milovanova L.
Chronic kidney disease risk factors in development of renal dysfunction in chronic heart failure patients
Kirshina N., Pimenov L.
Variants of renal osteodystrophy
Milovanov Y., Milovanova L., Kozlovskaya L.
CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION
Fomin V., Kiyakbaev G.
Perspectives on long-acting dihydropiridine calcium antagonists in treatment and prophylaxis of chronic kidney disease
Fomin V., Girina S., Fomin V., Girina S.
ESSENTIAL ARTERIAL HYPERTENSION AND CHRONIC RENAL FAILURE IN PATIENTS WITH LONG-TERM FOLLOW-UP IN MULTIDISCIPLINARY OUTPATIENT HEALTH CARE FACILITY
Alekseeva L., Popova L., Ryzhenkova I., Alekseeva L., Popova L., Ryzhenkova I.
Loop diuretic treatment: time for new options
Mind the gap in kidney care: translating what we know into what we do
Luyckx V., Tuttle K., Abdellatif D., Correa-Rotter R., Fung W., Haris A., Hsiao L., Khalife M., Kumaraswami L., Loud F., Raghavan V., Roumeliotis S., Sierra M., Ulasi I., Wang B., Lui S., Liakopoulos V., Balducci A.
The first case of successful pregnancy and natural childbirth in a patient on program hemodialysis in Uzbekistan
Daminov B., Azizov S., Sharapov O., Safoeva S.
Intestinal fatty acid binding protein as biomarker of enterocyte injury in patients with renal failure
Pyatchenkov M., Sherbakov E., Trandina A., Belskykh A.
Clinical and functional characteristics of mineral and bone disorders in chronic kidney disease
Murkamilov I., Fomin V., Murkamilova Z., Sabirova A., Sabirov I., Yusupov F., Maanaev T., Zakirov O., Gasanov K.
Prevalence of risk factors for cerebrovascular diseases in patients with end-stage renal disease
Murkamilov I., Sabirov I., Murkamilova Z., Fomin V., Sabirova A., Yusupov F., Kudaibergenova I., Maanaev T.
Beyond glycemic control: nephroprotective effects of glucagon-like peptide 1 receptor agonists
Shamkhalova M., Sklyanik I., Shestakova M.
Homocystein and folic acid in chronic kidney disease: clinical and predictive significance
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Yusupov F., Kudaibergenova I.
Endothelial dysfunction in patients with chronic kidney disease: prognostic potential of endothelin-1
Gasanov M., Panchenko M., Batyushin M., Bronovitskaya N., Razina A.
MicroRNAS and their significance in the population of dialysis patients
Rind A., Yesayan A., Kayukov I., Zaraysky M.
Hyperphosphatemia - the value and methods of correction
Shutov E., Sorokoletov S.
Gender features of cardiorenal relationships and cytokine status in patients with chronic kidney disease
Murkamilov I., Aitbaev K., Fomin V.
Experience of the use of iron oxyhydroxide complex for the treatment of hyperphosphatemia in patients with stage 5 diabetic chronic kidney disease at the stage of starting dialysis therapy
Batyushin M., Kastanayan A.
Features in managing patients with chronic kidney disease and type 2 diabetes: the need for a multidisciplinary approach
Mihajlova N., Tishkina S.
Renal function and cardio-renal relationship in patients with primary hypothyroidism and concurrent arterial hypertension
Nikolaeva A., Pimenov L.
Membranoproliferative glomerulonephritis: a new classification and pathogenesis
Yurova V., Kozlovskaya N.
Clinical and pathogenetic associations in atrial fibrillation with concomitant chronic kidney disease
Kijakbaev G., Fomin V., Krasnova T.
Pharmacoeconomic aspects of the treatment of anemia in russian patients with chronic kidney disease
Ryazhenov V., Gorokhova S.
Prevalence of type 2 diabetes mellitus in patients with chronic kidney disease in nizhnii novgorog region
Yarkova Ν., Borovkov N., Solov’ianova E., Filina L.
Early treatment with phosphate-binders and active metabolites of vitamin D in prevention of secondary hyperparathyreoidism in patients with chronic kidney disease on program hemodialysis
Milovanova L., Plotnikova A., Milovanov Y., Dobrosmyslov I., Anashkin V., Ilinih E., Yagupova T.
Acute kidney injury in coronary heart disease after revascularization procedure: risk factors and outcomes
Sigitova O., Bogdanova A.
Nephrocardioprotective role of the Klotho protein circulating form in patients with chronic kidney disease
Milovanova L., Milovanov Y., Kozlovskaya L.
Association of prehypertension with risk factors of chronic kidney disease, arterial hypertension and atherosclerosis
Burmagina A., Nikolaev A.
Korrektsiya giperfosfatemii pri khronicheskoy pochechnoy nedostatochnosti: rol' sevelamera
Shilov E.
Lipid metabolism in chronic kidney disease
Rudenko T., Kutyrina I., Shvetsov M., Rudenko T., Kutyrina I., Shvetsov M.
Prevalence of chronic kidney disease and it's etiological structure in patients with rheumatoid arthritis
Rebrov A., Voloshinova E., Tyapkina M.
DEVELOPMENT OF EARLY STAGES OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH OBESITY
Gallyamov M., Severova M., Surkova O.
Treatment of anemia in chronic kidney disease: the present, the past and the future
Shilo V., Denisov A.
Hypertensive nephropathy evolution in patients with metabolic syndrome
Galushkin A., Batyushin M., Terent'ev V., Gorblyanskiy Y., Stepkova V., Volikov N.
Chronic kidney disease and program of increase of life span in Russian Federation
Shilov E., Kozlovskaya N., Bobkova I., Shvetsov M., Vatazin A., Shilov E., Kozlovskaya N., Bobkova I., Shvetsov M., Vatazin A.
Optimization of loop diuretic therapy in chronic heart failure and chronic kidney disease
Kozlovskaya L., Fomin V., Moiseev S., Khamkhoeva M.
Left ventricular myocardial hypertrophy and its prognostic role at chronic kidney disease
Gendlin G., Shilo V., Tomilina N., Storozhakov G., Borisovskaya S., Ettinger O., Badaeva S., Gavryushina O., Gendlin G., Shilo V., Tomilina N., I Storogakov G., Borisovskaya S., Ettinger O., Badaeva S., Gavryushina O.
HIF-prolylhydroxylase inhibitors: the future for anemia treatment in patients with chronic kidney disease
Levchenkova O., Novikov V., Vorobyova V., Kozlov S.
Roxadustat: treatment of anemia and additional clinical effects (literature review)
Mikhailova N.
Secondary hyperparathyroidism in patients with chronic kidney disease in Tyumen region: five-year follow-up data
Avdeeva V., Syachina S., Eirich V., Zhmurov D., Zhmurov V.
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers
Moiseev S., Shchulkin A., Abalenikhina Y., Mylnikov P., Yakusheva E., Khmelevsky M., Macyak M.
Interleukin-6 receptor inhibitor levilimab in the treatment of COVID-19 in patients with chronic kidney disease
Frolova N., Tomilina N., Usatyuk S., Dyakova E., Sysoeva I., Terentyeva N., Frolov M., Kim I.
The functional state of the kidneys and albuminuria in individuals with cardiovascular risk factors
Mikhailova L., Shupina M., Safonova V., Butova V., Sheremet V.
The role of oxidative stress in the development of protein-energy wasting and sarcopenia in patients with stage 5D chronic kidney disease
Gasanov M., Negoda V., Batyushin M.
Prevalence of chronic kidney disease in primary care patients. results of a prospective observational study in 12 regions of Russia
Essaian A., Arutyunov G., Melikhov O.
Features of pathogenetic mechanisms of protein-energy wasting development in patients with chronic kidney disease stage 5D
Kuzyarova A., Gasanov M., Batyushin M., Bogomolova K., Adamokova I.
Membranous glomerulonephritis: a modern view of the problem and treatment options
Murkamilov I., Sabirov I., Fomin V., Murkamilova Z., Aitbaev K.
The mechanisms of chronic kidney disease progression: evolution of views
Plenkina L., Simonova O., Rozinova V.
The first russian darbepoetin alfa bioanalogue: results of a double-blind, randomized clinical study of efficacy and safety for patients with nephrogenic anemia on programmed hemodialysis
Shilo V., Babich V., Vasilieva G., Vishnevsky K., Gomova T., Doru-Tovt V., Dudarev M., Yeremeeva L., Zuev A., Kotova L., Novoseltsev I., Rodoman G., Ryasnyansky V., Sabodash A., Solovyova A., Solovyova O., Suchkov V., Strokov A., Timokhovskaya G., Chistyakov V., Shpagina L., Fedotova L., Khadikova N., Khazova E., Morozova M., Dokukina E., Lin’kov Y.
Contemporary opportunities for using phosphate binders in dialysis patients
Gorelova E., Chernysheva N., Kotenko O., Shutov E.
Analysis of the effect of markers of kidney injury related to the carbohydrate metabolism disorders on the risk of non-selective proteinuria
Ustinova M., Batiushin M.
Implications of low-protein diet and ketoanalogues of essential amino acids' supplementation for cardiovascular and renal protection in patients with chronic kidney disease
Kotenko O., Evstigneeva K.
Unresolver problem of calcium in phosphate-binding therapy of bone-mineral metabolism dis-turbances in patients with chronic kidney disease on program hemodialysis
Khoroshilov S.
Geometric models of left ventricular remodeling in patients with predialysis stages of chronic kidney disease
Aiypova D., Ahunova E., Kaliev R.
Magnesium-containing phosphate-binders: new therapeutic opportunities in chronic kidney disease
Mikhailova N.
Perspectives of sevelamer in hyperphosphatemia treatment in patients with chronic kidney disease stage III-V
Milovanova L., Milovanov Y., Dobrosmislov I., Moiseev S.
Use of continuous erythropoietin receptor activator in treatment of anemia in patients with predialysis chronic kidney disease
Milovanova L., Milovanov Y., Kozlovskaya L.
Serum levels of morphogenetic proteins (fibroblast growth factor-23 and Klotho): clinical significance
Milovanova L., Milovanov Y., Kozlovskaya L., Moukhin N.
Role of R990G polymorphism of calcium-sensing receptor gene in regulation of parathyroid hormone level in children with chronic kidney disease stage III-V
Molchanova M., Tikhomirov E., Bykova L., Molchanova E., Rumyantsev A., Valov A., Ektov D., Ektov V., Yurasova Y., Petrosyan E., Molchanova M., Tikhomirov E., Bykova L., Molchanova E., Rumiantsev A., Valov A., Ektov D., Ektov V., Yurasova Y., Petrosian E.
DIFFICULT NEPHROLOGICAL PATIENT TODAY
Mukhin N., Moukhin N.
Optimal target hemoglobin level in chronic kidney disease patients, treated with erythropoesis-stimulating agents: controversial questions
Kozlovskaya L., Milovanov Y., Milovanova L.
101 - 200 de 267 resultados << < 1 2 3 > >> 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.